Novel Ophthalmic Drug Delivery


Anatomy and physiology of the eye protect it from damage. It therefore minimizes the transport of medication by traditional dosage forms to the eye, and the therapeutic concentration of drugs may not be maintained for long periods of time. Ocular drug delivery systems allowed for long-term treatment of ocular infections by delivering medication directly to the anterior segment of the eye. For the treatment of chronic vitreoretinal diseases, different biodegradable or non-biodegradable polymer implants have been widely investigated. Developing ocular drug delivery systems that provide controlled release of medication can reduce the dosing frequency for chronic diseases.


  • Nanoparticles
  • Drug embedded contact lenses
  • Iontophorosis

Related Conference of Novel Ophthalmic Drug Delivery

September 16-17, 2024

2nd Annual Conference on Surgery

Paris, France
September 18-19, 2024

7th World Congress on Surgeons

Dubai, UAE
October 22-23, 2024

2nd Global Summit on Geriatrics & Aging

Paris, France
November 26-27, 2024

4th World Congress on Surgery

Zurich, Switzerland
November 28-29, 2024

15th European Conference on Surgery & Cosmetology

Paris, France
December 02-03, 2024

7th Annual Summit on Surgery and Transplantation

Prague, Czech Republic
February 24-25, 2025

11th International Conference on Surgeons

Madrid, Spain
May 19-20, 2025

10th International Conference on Surgery and Anaesthesia

Zurich, Switzerland

Novel Ophthalmic Drug Delivery Conference Speakers

    Recommended Sessions

    Related Journals

    Are you interested in